| Literature DB >> 23239950 |
Abstract
A decline in learning and memory is a feature of the normal aging process and associated with neurodegenerative diseases such as dementia and Alzheimer's disease. Moreover, certain forms of dementia and memory loss are inevitable due to the normal aging process. The unavoidable effect of age on memory is an ongoing study, as the findings assist in identifying cortical functions of the brain. Histone acetylation is a mechanism in synaptic plasticity and a key function in learning and memory because changes within the process alter gene transcription and the quantity of synthesized proteins. Similar to histone acetylation, environmental enrichment has also been found to improve memory formation by stimulating synaptic plasticity. Through understanding the mechanisms by which environmental enrichment and histone acetylation interact in the brain and affect learning and memory, novel applications can be developed for therapeutic interventions to neurodegenerative diseases and aging.Entities:
Keywords: HDAC inhibitors; aging; environmental enrichment; histone acetylation; learning and memory; neurodegenerative diseases
Mesh:
Substances:
Year: 2012 PMID: 23239950 PMCID: PMC3516891
Source DB: PubMed Journal: Yale J Biol Med ISSN: 0044-0086
Figure 1Environmental enrichment through increased social interaction, physical activity, and exploratory behavior can promote neuronal activation and synaptic plasticity.
Figure 2Histone acetylation regulated by histone acetyltransferases promotes transcription and new protein synthesis required for learning and memory.
Figure 3Possible mechanisms of EE and HDAC inhibitors on an aged or neurodegenerative model.
Summary of Effect of EE and HDAC Inhibitors on Learning, Memory, and HA.
|
|
|
|
|
| Normal Aging | EE | Increased learning and memory/Increased HA | [ |
| HDAC Inhibitor | Increasd learning and memory/Increased HA | [ | |
|
| |||
| Accelerated Aging | EE | Increased learning and memory/Increased HA | [ |
| HDAC Inhibitor | Increased learning and memory/Increased HA | [ | |
|
| |||
| Alzheimer's Disease | EE | Delay cognitive deficit/Increased HA | [ |
| HDAC Inhibitor | Increased learning and memory/Increased HA | [ | |
|
| |||
| Huntington's Disease | EE | Delay cognitive deficit/Increased HA | [ |
| HDAC Inhibitor | Increased learning and memory/Increased HA | [ | |
|
| |||
| Parkinson's Disease | EE | Improved motor function | [ |
| HDAC Inhibitor | Increased learning and memory/Increased HA | [ | |